Morgan Stanley
OASM

Morgan Stanley’s Oasmia Pharmaceutical AB OASM Stock Holding History

Morgan Stanley’s Portfolio OASM Stock Details OASM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5
Closed – – 6917
2019
Q2 		$0 Sell
5
-6
-55% -$11 ﹤0.01% 6874
2019
Q1 		$0 Sell
11
-1
-8% -$3 ﹤0.01% 6823
2018
Q4 		$0 Sell
12
-2,408
-100% -$9.51K ﹤0.01% 6850
2018
Q3 		$10K Buy
2,420
+2,419
+241,900% +$5.06K ﹤0.01% 6315
2018
Q2 		$0 Hold
1
– – ﹤0.01% 6834
2018
Q1 		$0 Hold
1
– – ﹤0.01% 6791
2017
Q4 		$0 Buy
+1
New +$1 ﹤0.01% 6747
2016
Q2 		– Sell
-3
Closed – – 6767
2016
Q1 		$0 Sell
3
-1
-25% -$4 ﹤0.01% 6822
2015
Q4 		$0 Buy
+4
New +$16 ﹤0.01% 6898

Morgan Stanley's OASM Position: Q3 2019 in Review

Morgan Stanley sold out of Oasmia Pharmaceutical AB (OASM) in Q3 2019, closing a stake of 5 shares.

Morgan Stanley first reported a position in OASM in Q4 2015 and held it in 9 quarters. The position peaked at $10K in Q3 2018. 0 funds tracked by Wall St. Rank hold OASM as of Q3 2019.

  • Morgan Stanley reported no remaining Oasmia Pharmaceutical AB position as of Q3 2019 after selling out during the quarter.
  • Morgan Stanley sold 5 Oasmia Pharmaceutical AB shares in Q3 2019.
  • Morgan Stanley first reported a position in Oasmia Pharmaceutical AB in Q4 2015 and held it in 9 quarters.
  • Morgan Stanley's Oasmia Pharmaceutical AB position peaked at $10K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Oasmia Pharmaceutical AB as of Q3 2019.

Based on Morgan Stanley's 13F filing for Q3 2019, filed 14 Nov 2019.